1	-LRB-	-LRB-	12	punct
2	During	IN	12	prep
3	its	PRP$	5	poss
4	centennial	JJ	5	amod
5	year	NN	2	pobj
6	,	,	12	punct
7	The	DT	10	det
8	Wall	NNP	9	nn
9	Street	NNP	10	nn
10	Journal	NNP	12	nsubj
11	will	MD	12	aux
12	report	VB	0	root
13	events	NNS	12	dobj
14	of	IN	13	prep
15	the	DT	17	det
16	past	JJ	17	amod
17	century	NN	14	pobj
18	that	DT	19	nsubj
19	stand	NN	13	rcmod
20	as	IN	19	prep
21	milestones	NNS	20	pobj
22	of	IN	21	prep
23	American	JJ	25	amod
24	business	NN	25	nn
25	history	NN	22	pobj
26	.	.	12	punct
27	-RRB-	-RRB-	12	punct

1	LUTHER	NNP	2	nn
2	BURBANK	NNP	3	nsubj
3	CROSS-BRED	VBD	0	root
4	PLANTS	NNS	3	dobj
5	to	TO	6	aux
6	produce	VB	3	xcomp
7	the	DT	10	det
8	billion-dollar	JJ	10	amod
9	Idaho	NNP	10	nn
10	potato	NN	6	dobj
11	.	.	3	punct

1	Bioengineers	NNS	2	nsubj
2	set	VBD	0	root
3	out	RP	2	prt
4	to	TO	5	aux
5	duplicate	VB	2	xcomp
6	that	DT	7	det
7	feat	NN	5	dobj
8	--	:	9	punct
9	scientifically	RB	5	dep
10	and	CC	9	cc
11	commercially	RB	9	conj
12	--	:	9	punct
13	with	IN	5	prep
14	new	JJ	16	amod
15	life	NN	16	nn
16	forms	NNS	13	pobj
17	.	.	2	punct

1	In	IN	9	prep
2	1953	CD	1	pobj
3	,	,	9	punct
4	James	NNP	5	nn
5	Watson	NNP	9	nsubj
6	and	CC	5	cc
7	his	PRP$	8	poss
8	colleagues	NNS	5	conj
9	unlocked	VBD	0	root
10	the	DT	12	det
11	double	JJ	12	amod
12	helix	NN	9	dobj
13	of	IN	12	prep
14	DNA	NN	13	pobj
15	-LRB-	-LRB-	17	punct
16	deoxyribonucleic	JJ	17	amod
17	acid	NN	14	appos
18	-RRB-	-RRB-	17	punct
19	,	,	14	punct
20	the	DT	22	det
21	genetic	JJ	22	amod
22	key	NN	14	appos
23	to	TO	22	prep
24	heredity	NN	23	pobj
25	.	.	9	punct

1	Twenty	CD	2	num
2	years	NNS	3	npadvmod
3	later	RB	15	advmod
4	,	,	15	punct
5	two	CD	7	num
6	California	NNP	7	nn
7	academics	NNS	15	nsubj
8	,	,	7	punct
9	Stanley	NNP	10	nn
10	Cohen	NNP	7	appos
11	and	CC	10	cc
12	Herbert	NNP	13	nn
13	Boyer	NNP	10	conj
14	,	,	7	punct
15	made	VBD	0	root
16	``	``	17	punct
17	recombinant	JJ	19	amod
18	''	''	17	punct
19	DNA	NN	15	dobj
20	,	,	15	punct
21	transplanting	VBG	15	partmod
22	a	DT	23	det
23	toad	NN	25	poss
24	's	POS	23	possessive
25	gene	NN	21	dobj
26	into	IN	21	prep
27	bacteria	NNS	26	pobj
28	,	,	27	punct
29	which	WDT	31	nsubj
30	then	RB	31	advmod
31	reproduced	VBD	27	rcmod
32	toad	NN	33	nn
33	genes	NNS	31	dobj
34	.	.	15	punct

1	When	WRB	3	advmod
2	Boyer	NNP	3	nsubj
3	met	VBD	14	advcl
4	Robert	NNP	5	nn
5	Swanson	NNP	3	dobj
6	,	,	5	punct
7	an	DT	9	det
8	M.I.T.-trained	JJ	9	amod
9	chemist-turned-entrepreneur	NN	5	appos
10	in	IN	3	prep
11	1976	CD	10	pobj
12	,	,	14	punct
13	they	PRP	14	nsubj
14	saw	VBD	0	root
15	dollar	NN	16	nn
16	signs	NNS	14	dobj
17	.	.	14	punct

1	With	IN	13	prep
2	$	$	1	pobj
3	500	CD	2	num
4	apiece	RB	2	advmod
5	and	CC	2	cc
6	an	DT	7	det
7	injection	NN	2	conj
8	of	IN	7	prep
9	outside	JJ	10	amod
10	capital	NN	8	pobj
11	,	,	13	punct
12	they	PRP	13	nsubj
13	formed	VBD	0	root
14	Genentech	NNP	15	nn
15	Inc	NNP	13	dobj
16	.	.	13	punct

1	Commercial	JJ	2	amod
2	gene-splicing	NN	4	nsubjpass
3	was	VBD	4	auxpass
4	born	VBN	0	root
5	.	.	4	punct

1	Genentech	NNP	4	poss
2	's	POS	1	possessive
3	first	JJ	4	amod
4	product	NN	12	nsubj
5	,	,	4	punct
6	a	DT	8	det
7	brain	NN	8	nn
8	protein	NN	4	appos
9	called	VBD	8	partmod
10	somatostatin	NN	9	dep
11	,	,	4	punct
12	proved	VBD	0	root
13	its	PRP$	14	poss
14	technology	NN	12	dobj
15	.	.	12	punct

1	The	DT	2	det
2	next	JJ	10	nsubj
3	to	TO	5	aux
4	be	VB	5	auxpass
5	cloned	VBN	2	infmod
6	,	,	2	punct
7	human	JJ	8	amod
8	insulin	NN	2	appos
9	,	,	2	punct
10	had	VBD	0	root
11	market	NN	12	nn
12	potential	NN	10	dobj
13	and	CC	10	cc
14	Genentech	NNP	15	nsubj
15	licensed	VBD	10	conj
16	it	PRP	15	dobj
17	to	TO	15	prep
18	Eli	NNP	19	nn
19	Lilly	NNP	17	pobj
20	,	,	19	punct
21	which	WDT	22	nsubj
22	produced	VBD	19	rcmod
23	80	CD	24	num
24	%	NN	22	dobj
25	of	IN	24	prep
26	the	DT	27	det
27	insulin	NN	25	pobj
28	used	VBN	27	partmod
29	by	IN	28	prep
30	1.5	CD	31	number
31	million	CD	33	num
32	U.S.	NNP	33	nn
33	diabetics	NNS	29	pobj
34	.	.	10	punct

1	Their	PRP$	3	poss
2	laboratory	NN	3	nn
3	credentials	NNS	4	nsubj
4	established	VBN	9	partmod
5	,	,	9	punct
6	Boyer	NNP	9	nsubj
7	and	CC	6	cc
8	Swanson	NNP	6	conj
9	headed	VBD	0	root
10	for	IN	9	prep
11	Wall	NNP	12	nn
12	Street	NNP	10	pobj
13	in	IN	9	prep
14	1980	CD	13	pobj
15	.	.	9	punct

1	At	IN	6	prep
2	the	DT	3	det
3	time	NN	1	pobj
4	,	,	6	punct
5	Genentech	NN	6	nsubj
6	had	VBD	0	root
7	only	RB	10	advmod
8	one	CD	10	num
9	profitable	JJ	10	amod
10	year	NN	6	dobj
11	behind	IN	10	prep
12	it	PRP	11	pobj
13	-LRB-	-LRB-	16	punct
14	a	DT	16	det
15	modest	JJ	16	amod
16	$	$	10	dep
17	116,000	CD	16	num
18	on	IN	16	prep
19	revenue	NN	18	pobj
20	of	IN	19	prep
21	$	$	20	pobj
22	2.6	CD	21	number
23	million	CD	21	number
24	in	IN	19	prep
25	1979	CD	24	pobj
26	-RRB-	-RRB-	16	punct
27	and	CC	10	cc
28	no	DT	29	det
29	product	NN	10	conj
30	of	IN	29	prep
31	its	PRP$	32	poss
32	own	JJ	30	pobj
33	on	IN	29	prep
34	the	DT	35	det
35	market	NN	33	pobj
36	.	.	6	punct

1	Nonetheless	RB	12	advmod
2	,	,	12	punct
3	the	DT	7	det
4	$	$	7	num
5	36	CD	4	number
6	million	CD	4	number
7	issue	NN	12	nsubj
8	they	PRP	9	nsubj
9	floated	VBD	7	rcmod
10	in	IN	9	prep
11	1980	CD	10	pobj
12	opened	VBD	0	root
13	at	IN	12	prep
14	$	$	13	pobj
15	35	CD	14	num
16	and	CC	12	cc
17	leaped	VBD	12	conj
18	to	TO	17	prep
19	$	$	18	pobj
20	89	CD	19	num
21	within	IN	17	prep
22	20	CD	23	num
23	minutes	NNS	21	pobj
24	.	.	12	punct

1	The	DT	2	det
2	trip	NN	7	nsubj
3	from	IN	2	prep
4	the	DT	6	det
5	test	NN	6	nn
6	tube	NN	3	pobj
7	was	VBD	0	root
8	not	RB	7	neg
9	without	IN	7	prep
10	snags	NNS	9	pobj
11	.	.	7	punct

1	Boyer	NNP	13	nsubj
2	and	CC	1	cc
3	Cohen	NNP	1	conj
4	,	,	5	punct
5	for	IN	1	dep
6	instance	NN	5	pobj
7	,	,	5	punct
8	both	DT	11	det
9	still	RB	11	advmod
10	university	NN	11	nn
11	researchers	NNS	1	dep
12	,	,	1	punct
13	had	VBD	0	root
14	to	TO	16	aux
15	be	VB	16	auxpass
16	talked	VBN	13	xcomp
17	into	IN	16	prep
18	applying	VBG	17	pcomp
19	for	IN	18	prep
20	a	DT	21	det
21	patent	NN	19	pobj
22	on	IN	21	prep
23	their	PRP$	25	poss
24	gene-splicing	NN	25	nn
25	technique	NN	22	pobj
26	--	:	13	punct
27	and	CC	13	cc
28	then	RB	13	advmod
29	the	DT	31	det
30	Patent	NNP	31	nn
31	Office	NNP	32	nsubj
32	refused	VBD	13	ccomp
33	to	TO	34	aux
34	grant	VB	32	xcomp
35	it	PRP	34	dobj
36	.	.	13	punct

1	That	DT	2	det
2	judgment	NN	8	nsubjpass
3	,	,	8	punct
4	in	IN	8	prep
5	turn	NN	4	pobj
6	,	,	8	punct
7	was	VBD	8	auxpass
8	reversed	VBN	0	root
9	by	IN	8	prep
10	the	DT	13	det
11	U.S.	NNP	13	nn
12	Supreme	NNP	13	nn
13	Court	NNP	9	pobj
14	,	,	8	punct
15	leaving	VBG	8	xcomp
16	Cohen	NNP	19	nsubj
17	and	CC	16	cc
18	Boyer	NNP	16	conj
19	holding	VBG	15	dep
20	the	DT	22	det
21	first	JJ	22	amod
22	patents	NNS	19	dobj
23	for	IN	22	prep
24	making	VBG	23	pcomp
25	recombinant	JJ	26	amod
26	DNA	NNP	24	dobj
27	-LRB-	-LRB-	29	punct
28	now	RB	29	advmod
29	assigned	VBN	22	dep
30	to	TO	29	prep
31	their	PRP$	32	poss
32	schools	NNS	30	pobj
33	-RRB-	-RRB-	29	punct
34	.	.	8	punct

1	Gene-splicing	NN	6	nsubj
2	now	RB	6	advmod
3	is	VBZ	6	cop
4	an	DT	6	det
5	integral	JJ	6	amod
6	part	NN	0	root
7	of	IN	6	prep
8	the	DT	10	det
9	drug	NN	10	nn
10	business	NN	7	pobj
11	.	.	6	punct

1	Genentech	NN	4	poss
2	's	POS	1	possessive
3	1988	CD	4	num
4	sales	NNS	6	nsubj
5	were	VBD	6	cop
6	$	$	0	root
7	335	CD	6	number
8	million	CD	6	number
9	,	,	6	punct
10	both	CC	11	preconj
11	from	IN	6	prep
12	licensing	NN	11	pobj
13	and	CC	11	cc
14	its	PRP$	16	poss
15	own	JJ	16	amod
16	products	NNS	11	conj
17	.	.	6	punct


